Detection of Diagnostic Biomarkers for Kawasaki Disease Using Proteomic Analysis

Detection of Diagnostic Biomarkers for Kawasaki Disease Using Proteomic Analysis - Detection of Diagnostic Biomarkers for Kawasaki Disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021329

Enrollment

Registered

2016-03-04

Start date

2015-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The subjects of this study were the patients with KD aged 1 month to 10 years in the acute phase and the recovery phase. The diagnosis of KD was performed according to clinical criteria. The acute phase is defined as the febrile period before intervention. The recovery phase is defined as the afebrile period following intervention. We use the samples from the other illnesses aged from 0 to 10 years who were divided into group 1 (G1; viral infection), group 2 (G2; bacterial infection), and group 3 (G3; autoimmune disease), and healthy subjects aged 1 month to 10 years served as a control group.

Exclusion criteria

Exclusion criteria: The child who is not obtained the consent by a parent or the person in the groups mentioned above

Design outcomes

Primary

Measure	Time frame
To find the biomarkers used to establish a new diagnostic method for elucidating KD pathogenesis potentially	—

Countries

Japan

Contacts

Public ContactMasaaki Mori

Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University Department of Pharmacovigilance

mori.phv@tmd.ac.jp+81-3-5803-4876

Outcome results